Lindbrook Capital’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$37.8K Buy
924
+881
+2,049% +$42.4K ﹤0.01% 1114
2024
Q4
$2.33K Sell
43
-14
-25% -$802 ﹤0.01% 2267
2024
Q3
$3.7K Sell
57
-35
-38% -$2.25K ﹤0.01% 2135
2024
Q2
$5.7K Buy
92
+57
+163% +$3.96K ﹤0.01% 1937
2024
Q1
$2.96K Hold
35
﹤0.01% 2105
2023
Q4
$2.62K Hold
35
﹤0.01% 2170
2023
Q3
$2.42K Hold
35
﹤0.01% 2057
2023
Q2
$2.54K Buy
35
+18
+106% +$1.22K ﹤0.01% 2056
2023
Q1
$1.22K Sell
17
-24
-59% -$1.84K ﹤0.01% 2409
2022
Q4
$3.06K Buy
41
+33
+413% +$2.36K ﹤0.01% 2045
2022
Q3
$1K Buy
+8
New +$613 ﹤0.01% 2277
2019
Q3
Sell
-11
Closed -$1K 1449
2019
Q2
$1K Hold
11
﹤0.01% 1313
2019
Q1
$1K Hold
11
﹤0.01% 1289
2018
Q4
$0 Buy
+11
New +$1K ﹤0.01% 1365

Other funds holding CRI

Lindbrook Capital's CRI Position: Q1 2025 in Review

Lindbrook Capital increased its Carter's (CRI) stake by 2,049% in Q1 2025, buying an estimated $42.4K and bringing the position to 924 shares worth $37.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Lindbrook Capital first reported a position in CRI in Q4 2018 and has held it in 14 quarters since. 286 funds tracked by Wall St. Rank hold CRI as of Q1 2025.

  • Lindbrook Capital held 924 shares of Carter's worth $37.8K as of Q1 2025.
  • Lindbrook Capital bought 881 Carter's shares in Q1 2025, an estimated $42.4K.
  • Carter's made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1114 holding.
  • Lindbrook Capital first reported a position in Carter's in Q4 2018 and has held it in 14 quarters since.
  • 286 funds tracked by Wall St. Rank held Carter's as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.